| MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism K Mallilankaraman, C Cárdenas, PJ Doonan, HC Chandramoorthy, ... Nature cell biology 14 (12), 1336-1343, 2012 | 594 | 2012 |
| Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators T Tahara, E Yamamoto, P Madireddi, H Suzuki, R Maruyama, W Chung, ... Gastroenterology 146 (2), 530-538. e5, 2014 | 138 | 2014 |
| Targeting calcium signaling induces epigenetic reactivation of tumor suppressor genes in cancer NJM Raynal, JT Lee, Y Wang, A Beaudry, P Madireddi, J Garriga, ... Cancer research 76 (6), 1494-1505, 2016 | 109 | 2016 |
| Gadd45b deficiency promotes premature senescence and skin aging A Magimaidas, P Madireddi, S Maifrede, K Mukherjee, B Hoffman, ... Oncotarget 7 (19), 26935, 2016 | 23 | 2016 |
| MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism. K Mallilankaraman, C Cárdenas, PJ Doonan, HC Chandramoorthy, ... Nature Cell Biology 15 (1), 2013 | 15 | 2013 |
| Demethylator phenotypes in acute myeloid leukemia AD Kelly, J Madzo, P Madireddi, P Kropf, CR Good, J Jelinek, JPJ Issa Leukemia 32 (10), 2178-2188, 2018 | 9 | 2018 |
| As “SIRT” ing the role of an epigenetic modifier in hematopoietic stem cell homeostasis A Magimaidas, R Badolia, P Madireddi, D Bhavanasi Stem Cell Investigation 3, 2016 | 2 | 2016 |
| Abstract A017: Patient-reported experience related to aspects of quality of life after cystectomy from an exploratory focus group N Imran, W Peters, K Fixler, P Madireddi, LM Shea, A Ireland Clinical Cancer Research 30 (10_Supplement), A017-A017, 2024 | | 2024 |
| A DNMT3A-independent hypomethylator phenotype is a unifying epigenetic signature of AML with good risk cytogenetics AD Kelly, J Madzo, P Madireddi, P Kropf, CR Good, J Jelinek, JPJ Issa Cancer Research 77 (13_Supplement), 5382-5382, 2017 | | 2017 |
| Very low methylation is a novel epigenetic regulatory mechanism in normal tissues and predisposes to hypermethylation in cancer P Madireddi, J Jelinek, J Lee, T Sato, JP Issa Cancer Research 76 (14_Supplement), 4442-4442, 2016 | | 2016 |
| Low level methylation (1-20%) or methylation seeds is a distinct epigenetic regulator of gene expression and is a strong predictor of methylation gains in AML and MDS patients P Madireddi, J Jelinek, J Lee, M Cesaroni, R Rodrigues, Y Zhang, JP Issa Cancer Research 75 (15_Supplement), 2954-2954, 2015 | | 2015 |
| The role of cis- and trans-acting factors in regulation of DNA methylation P Madireddi Temple University, 2015 | | 2015 |
